12:12 PM EST - Oncolytics Biotech® Inc. : Announced a poster presentation made at the American Society of Hematology (ASH) Annual Meeting & Exposition taking place December 1-4 in San Diego, California. The poster highlights pelareorep’s ability to increase PD-L1 expression on tumor cells in patients with relapsed myeloma. Oncolytics Biotech® Inc.
shares T.ONC are trading down $0.16 at $3.34.